Clinical Trials of Novel Targeted Therapies in Ovarian Cancer: Moving Beyond Poly ADP Ribose Polymerase (PARP) InhibitorsQuan Guo, Steve Jia, Qing Yang et al.|Current Pharmaceutical Biotechnology|2018Cited by 6
Targeted therapy clinical trials in ovarian cancer: improved outcomes by gene mutation screeningQuan Guo, Steve Jia, Igor Nikoulin et al.|Anti-Cancer Drugs|2019Cited by 6